| 1 |
32477943 | Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro. | 2020 |
1 |
| 2 |
30135242 | Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine. | 2018 Nov |
1 |
| 3 |
28031414 | Inhibition of the Human ABC Efflux Transporters P-gp and BCRP by the BDE-47 Hydroxylated Metabolite 6-OH-BDE-47: Considerations for Human Exposure. | 2017 Jan |
1 |
| 4 |
27300692 | Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier. | 2016 |
3 |
| 5 |
27780535 | Etravirine inhibits ABCG2 drug transporter and affects transplacental passage of tenofovir disoproxil fumarate. | 2016 Nov |
1 |
| 6 |
24903205 | WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells. | 2014 Aug |
1 |
| 7 |
21935580 | Arginine 482 to glycine mutation in ABCG2/BCRP increases etoposide transport and resistance to the drug in HEK-293 cells. | 2012 Jan |
1 |
| 8 |
22614107 | Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance. | 2012 Sep |
1 |
| 9 |
19059384 | Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478. | 2009 Mar 1 |
3 |
| 10 |
18657189 | Is ATP binding responsible for initiating drug translocation by the multidrug transporter ABCG2? | 2008 Sep |
1 |
| 11 |
16981002 | Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter. | 2006 Nov |
1 |
| 12 |
12920197 | Breast cancer resistance protein exports sulfated estrogens but not free estrogens. | 2003 Sep |
2 |